RWB Health Inc.

EFFECT effective

RWB Health Inc. is a development-stage company offering 3,000,000 shares of common stock at $0.025 per share to raise $75,000. The company holds exclusive licensing rights to sell Natures Life CBD products in North America and non-exclusive global rights. It plans to focus on direct-to-consumer e-commerce and wholesale distribution, with no existing public market for its securities. The offering is self-underwritten by CEO Gabriel Voinea, who has committed to interest-free financing for the company.

S-1/A amended

Price $0.03 · Range $0.03 to $0.03 · 3,000,000 shares · Gross proceeds $75,000

RWB Health Inc. is a development-stage company offering 3,000,000 shares of common stock at $0.025 per share to raise $75,000. The self-underwritten offering, led by CEO Gabriel Voinea, aims to fund operations in the CBD product market. The company holds an exclusive license for Natures Life CBD products in North America and has minimal revenue ($8,940) with a net income of $1,690 as of December 2025. Risks include lack of market liquidity, dependence on a single product license, and uncertainty about future operations.

S-1/A amended

Price $0.03 · 3,000,000 shares · Gross proceeds $75,000

RWB Health Inc. is a development-stage company offering 3,000,000 shares of common stock at $0.025 per share in a self-underwritten offering. The company aims to raise $75,000 to fund operations, with proceeds intended for business development. It holds exclusive licensing rights for Natures Life CBD products in North America and non-exclusive global rights. The company has minimal revenue ($8,940) and net income ($1,690) as of December 2025, with an audit opinion expressing substantial doubt about its ability to continue as a going concern. No public trading market exists for its shares, and the offering is subject to risks including reliance on a single shareholder and lack of market liquidity.

S-1/A amended

Price $0.03 · 3,000,000 shares · Gross proceeds $75,000

RWB Health, Inc. is a newly incorporated company focused on selling CBD products in North America, with an exclusive license to distribute Natures Life CBD products. The company plans to raise $75,000 through a direct public offering of 3 million shares at $0.025 per share. The offering is self-underwritten with no minimum purchase requirements, and proceeds will fund business operations. The company has limited revenue history, a going concern uncertainty, and no public trading market for its shares. It relies on a single executive, Gabriel Voinea, and faces risks related to market acceptance, regulatory compliance, and dependence on a single product license.

S-1 filed

Price $0.03 · Range $0.03 to $0.03 · 3,000,000 shares · Gross proceeds $75,000

RWB Health, Inc. is a newly incorporated Nevada company seeking to raise $75,000 through a direct primary offering of 3,000,000 common shares at $0.025 per share. The company holds an exclusive license to distribute Natures Life CBD products in North America and non-exclusive global rights. It plans to operate as a direct-to-consumer e-commerce business and wholesale distributor, with limited financial history (revenues of $8,940 and net income of $1,690 as of December 2025). The offering is self-underwritten with no minimum purchase requirements, and the company lacks a public trading market for its shares.